Ronald Evans
Tracked across 1 events · 6 articles · First seen Jun 09, 2026 · Last active Jun 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Ronald Evans, a professor at the Salk Institute for Biological Studies and co-author of the study, emphasized the novel approach of using vitamin D analogs to overcome therapeutic resistance in pancreatic cancer. His expertise and commentary are central to the study's interpretation.
Jun 09, 2026 · 6 articles
60
Ronald Evans commented on approachVitamin D Boosts...
ERGEN INTELLIGENCE
Track Ronald Evans live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard